Apple (NASDAQ:AAPL) – The European Court of Justice ruled against Apple in a tax case regarding benefits...
By Michael Susin AstraZeneca said that its drug Enhertu, which it developed in partnership with Daiichi Sankyo, has been approved in the European...
By Ben Glickman Merck and Daiichi Sankyo agreed to jointly develop and commercialize three potential cancer treatments in a deal worth up to $22...
By Christian Moess Laursen AstraZeneca said trial results for its breast cancer drug Dato-DXd showed significant improvement for the primary...
By Christian Moess Laursen AstraZeneca said its lung-cancer drug Enhertu has been recommended for approval in the European Union following...
By Anthony O. Goriainoff AstraZeneca and Daiichi Sankyo said that datopotamab deruxtecan, a cancer drug, combined with the Imfinzi cancer...
By Anthony O. Goriainoff AstraZeneca said Monday that its datopotamab deruxtecan treatment showed positive results in patients with advanced...
By Elena Vardon AstraZeneca said Monday that the phase II trial for its cancer drug Enhertu showed clinically meaningful and durable responses...
By Kyle Morris AstraZeneca PLC said Monday that Enhertu has been recommended for approval in the European Union for patients with gastric cancer...
By Michael Susin AstraZeneca PLC and Daiichi Sankyo Co. have said that their antibody drug Enhertu has been approved by the U.S. Food and Drug...
By Ian Walker AstraZeneca PLC said Tuesday that initial results from a trial of datopotamab deruxtecan-based combinations show promising clinical...
By Jaime Llinares Taboada AstraZeneca PLC said Monday that its Enhertu drug has been recommended for approval in the European Union for patients...
By Michael Susin AstraZeneca PLC said on Thursday that its metastatic breast cancer treatment Enhertu has been approved for use in the U.S. The...
By Anthony O. Goriainoff AstraZeneca PLC and Daiichi Sankyo Co. said Tuesday that Enhertu, a cancer treatment, has been accepted by the U.S. Food...
By Jaime Llinares Taboada AstraZeneca PLC and Daiichi Sankyo Co. on Monday reported positive Phase 3 trial results for the Enhertu treatment on...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads